Get started
Author

Ana Mingorance

Quality of life and comorbidities associated with Dravet syndrome severity: a multinational cohort survey
2017 · Lieven Lagae, Isabella Brambilla, et al. · Developmental Medicine & Child Neurology · 203
PDF
Cerebellar GABAergic progenitors adopt an external granule cell-like phenotype in the absence of Ptf1a transcription factor expression
2007 · Marta Pascual, Ibane Abasolo, et al. · Proceedings of the National Academy of Sciences · 200
Regulation of Nogo and Nogo receptor during the development of the entorhino-hippocampal pathway and after adult hippocampal lesions
2004 · Ana Mingorance, Xavier Fontana, et al. · Molecular and Cellular Neuroscience · 107
Involvement of the Myelin-Associated Inhibitor Nogo-A in Early Cortical Development and Neuronal Maturation
2006 · Ana Mingorance-Le Meur, Binhai Zheng, et al. · Cerebral Cortex · 82
Epilepsy and neuropsychiatric comorbidities in mice carrying a recurrent Dravet syndrome SCN1A missense mutation
2019 · Ana Ricobaraza, Lucia Mora-Jimenez, et al. · Scientific Reports · 80
PDF
The European patient with Dravet syndrome: Results from a parent-reported survey on antiepileptic drug use in the European population with Dravet syndrome
2015 · Luis Miguel Aras, Julián Isla, et al. · Epilepsy & Behavior · 79
PDF
Nogo-A Expression in the Human Hippocampus in Normal Aging and in Alzheimer Disease
2006 · Vanessa Gil, Oriol Nicolas, et al. · Journal of Neuropathology & Experimental Neurology · 73
New In Vitro Phenotypic Assay for Epilepsy: Fluorescent Measurement of Synchronized Neuronal Calcium Oscillations
2014 · Nathalie Pacico, Ana Mingorance-Le Meur · PLoS ONE · 70
PDF
Genetic epilepsies and COVID‐19 pandemic: Lessons from the caregiver perspective
2020 · Ángel Aledo‐Serrano, Ana Mingorance, et al. · Epilepsia · 49
PDF
Regeneration of lesioned entorhino‐hippocampal axons in vitro by combined degradation of inhibitory proteoglycans and blockade of Nogo‐66/NgR signaling
2006 · Ana Mingorance, Marta Solé, et al. · The FASEB Journal · 49
PrP(106–126) activates neuronal intracellular kinases and Egr1 synthesis through activation of NADPH‐oxidase independently of PrPc
2005 · Rosalina Gavín, Nathalie Braun, et al. · FEBS Letters · 32
Gene therapies for neurogenetic disorders
2025 · Orrin Devinsky, Jeff Coller, et al. · Trends in Molecular Medicine · 31
Overexpression of myelin-associated glycoprotein after axotomy of the perforant pathway
2005 · Ana Mingorance, Xavier Fontana, et al. · Molecular and Cellular Neuroscience · 24
Treatment Guidelines for Rare, Early-Onset, Treatment-Resistant Epileptic Conditions: A Literature Review on Dravet Syndrome, Lennox-Gastaut Syndrome and CDKL5 Deficiency Disorder
2021 · Richard F. Chin, Ana Mingorance, et al. · Frontiers in Neurology · 21
Análisis del impacto familiar y necesidades del síndrome de Dravet en España
2020 · Ángel Aledo Serrano, Ana Mingorance · Revista de Neurología · 17
Semaphorin 6C leads to GSK-3-dependent growth cone collapse and redistributes after entorhino-hippocampal axotomy
2006 · Ferran Burgaya, Xavier Fontana, et al. · Molecular and Cellular Neuroscience · 17
Diagnostic gap in genetic epilepsies: A matter of age
2020 · Angel Aledo-Serrano, Irene García-Morales, et al. · Epilepsy & Behavior · 16
Epilepsy Benchmarks Area II: Prevent Epilepsy and Its Progression
2020 · Devin K. Binder, Detlev Boison, et al. · Epiliepsy currents/Epilepsy currents · 15
Varicones and Growth Cones: Two Neurite Terminals in PC12 Cells
2009 · Ana Mingorance-Le Meur, Alma N. Mohebiany, et al. · PLoS ONE · 15
PDF
Drivers of Orphan Drug Development
2018 · Ana Mingorance · ACS Medicinal Chemistry Letters · 13
PDF
Clinical trial strategies for rare neurodevelopmental disorders: challenges and opportunities
2021 · Michelle L. Krishnan, Elizabeth Berry-Kravis, et al. · Nature Reviews Drug Discovery · 12
PDF
Gene therapies and COVID-19 vaccines: a necessary discussion in relation with viral vector-based approaches
2021 · Angel Aledo-Serrano, Antonio Gil-Nagel, et al. · Orphanet Journal of Rare Diseases · 10
PDF
The Charlotte Project: Recommendations for patient-reported outcomes and clinical parameters in Dravet syndrome through a qualitative and Delphi consensus study
2022 · Ángel Aledo-Serrano, Ana Mingorance, et al. · Frontiers in Neurology · 9
Baseline characteristics and feasibility of clinical outcome measures in CDKL5 deficiency disorder: The CANDID observational study
2026 · Xavier Liogier d'Ardhuy, CANDID Partners, et al. · Epilepsia · 2
PDF
DISCUSS Dravet – Key socioeconomic findings from a large multinational survey of Dravet syndrome caregivers
2017 · Lieven Lagae, Isabella Brambilla, et al. · European Journal of Paediatric Neurology · 2
Works count: 29
Citation count: 1,229
H-index: 16
I10-index: 22
Year
Topic
Type